0001209191-17-041062.txt : 20170620
0001209191-17-041062.hdr.sgml : 20170620
20170620160709
ACCESSION NUMBER: 0001209191-17-041062
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170617
FILED AS OF DATE: 20170620
DATE AS OF CHANGE: 20170620
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CELGENE CORP /DE/
CENTRAL INDEX KEY: 0000816284
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 222711928
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
BUSINESS PHONE: (908)673-9000
MAIL ADDRESS:
STREET 1: 86 MORRIS AVENUE
CITY: SUMMIT
STATE: NJ
ZIP: 07901
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: CASEY MICHAEL D
CENTRAL INDEX KEY: 0001190435
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34912
FILM NUMBER: 17920932
MAIL ADDRESS:
STREET 1: ALLOS THERAPEUTICS, INC.
STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200
CITY: WESTMINSTER
STATE: CO
ZIP: 80020
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-17
0
0000816284
CELGENE CORP /DE/
CELG
0001190435
CASEY MICHAEL D
C/O CELGENE CORPORATION
86 MORRIS AVENUE
SUMMIT
NJ
07901
1
0
0
0
Common Stock
2017-06-17
4
M
0
333
0.00
A
0
D
Common Stock
2017-06-19
4
S
0
9250
125.59
A
0
D
Common Stock
92070
I
Family Trust
Restricted Stock Unit
2017-06-17
4
M
0
333
0.00
D
Common Stock
333
334
D
One-third of the restricted stock units granted to the reporting person on June 17, 2015 vested and settled for shares of the Company's common stock.
The price reported in Column 4 is a weighted average price. These shares were sold by the reporting person in multiple transactions at prices ranging from $125.57 to $125.60, inclusive. The reporting person undertakes to provide Celgene Corporation (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
The reporting person disclaims beneficial ownership of these securities and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
The balance of the restricted stock units will vest on June 17, 2018. Vested shares will be delivered to the reporting person promptly after the vesting date.
The restricted stock units were issued pursuant to the Company's 2017 Stock Incentive Plan (formerly known as the 2008 Stock Incentive Plan (as amended and restated on April 15, 2015)).
/s/ Peter N. Kellogg, Attorney-in-Fact
2017-06-20